347 related articles for article (PubMed ID: 24793952)
41. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.
Yerkovich ST; Rowe J; Richmond P; Suriyaarachchi D; Heaton T; Hollams E; Ladyman C; Serralha M; Sadowska A; Loh R; Wesselingh SL; Sly PD; Holt PG
Vaccine; 2007 Feb; 25(10):1764-70. PubMed ID: 17224218
[TBL] [Abstract][Full Text] [Related]
42. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
43. Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation.
Hostetler HP; Neely ML; Lydon E; Danziger-Isakov LA; Todd JL; Palmer SM
Am J Transplant; 2021 Aug; 21(8):2864-2870. PubMed ID: 33840158
[TBL] [Abstract][Full Text] [Related]
44. The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.
Samoilovich EO; Kapustik LA; Feldman EV; Yermolovich MA; Svirchevskaya AJ; Zakharenko DF; Fletcher MA; Titov LP
Cent Eur J Public Health; 2000 Aug; 8(3):160-3. PubMed ID: 10965439
[TBL] [Abstract][Full Text] [Related]
45. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry.
Ramondetti F; Sacco S; Comelli M; Bruno G; Falorni A; Iannilli A; d'Annunzio G; Iafusco D; Songini M; Toni S; Cherubini V; Carle F;
Diabet Med; 2012 Jun; 29(6):761-6. PubMed ID: 22133003
[TBL] [Abstract][Full Text] [Related]
46. Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults.
Kakoulidou M; Ingelman-Sundberg H; Johansson E; Cagigi A; Farouk SE; Nilsson A; Johansen K
Vaccine; 2013 Jan; 31(4):711-7. PubMed ID: 23174196
[TBL] [Abstract][Full Text] [Related]
47. Humoral immunity to tetanus, measles and rubella in children with acute lymphoblastic leukemia after chemotherapy.
Onorateli M; Botana C; Peralta L; Rebollo M; Ruvinsky S; Guitter M; Felice MS; Posadas M; Evangelista S; Villar MV; Golluscio M; Molina A; Fraquelli L
Arch Argent Pediatr; 2016 Dec; 114(6):549-552. PubMed ID: 27869413
[TBL] [Abstract][Full Text] [Related]
48. [Cytostatic therapy reduces the immune defense. Children treated for leukemia have impaired immunity against measles and rubella].
Nilsson A; Nordin M; De Milito A; Grillner L; Chiodi F; Björk O
Lakartidningen; 2000 Nov; 97(45):5116-8. PubMed ID: 11116890
[TBL] [Abstract][Full Text] [Related]
49. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.
Naganuma M; Nagahori M; Fujii T; Morio J; Saito E; Watanabe M
Inflamm Bowel Dis; 2013 Feb; 19(2):418-22. PubMed ID: 22605673
[TBL] [Abstract][Full Text] [Related]
50. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Laws HJ; Calaminus G; Göbel U
Cancer; 2005 Apr; 103(8):1759; author reply 1760. PubMed ID: 15717299
[No Abstract] [Full Text] [Related]
51. Measles, mumps, rubella, and varicella seroprevalence in refugees in Germany in 2015.
Jablonka A; Happle C; Grote U; Schleenvoigt BT; Hampel A; Dopfer C; Hansen G; Schmidt RE; Behrens GM
Infection; 2016 Dec; 44(6):781-787. PubMed ID: 27449329
[TBL] [Abstract][Full Text] [Related]
52. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P
Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835
[TBL] [Abstract][Full Text] [Related]
53. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
[TBL] [Abstract][Full Text] [Related]
54. [Value of salivary antibodies for determining seropositivity to measles, rubella, and mumps in children and adults].
Garrido Redondo M; Blanco Quirós A; Garrote Adrados JA; Tellería Orriols JJ; Arranz Sanz E
An Esp Pediatr; 1997 Nov; 47(5):499-504. PubMed ID: 9586291
[TBL] [Abstract][Full Text] [Related]
55. Response to early measles-mumps-rubella vaccination in infants with chronic renal failure and/or receiving peritoneal dialysis.
Flynn JT; Frisch K; Kershaw DB; Sedman AB; Bunchman TE
Adv Perit Dial; 1999; 15():269-72. PubMed ID: 10682116
[TBL] [Abstract][Full Text] [Related]
56. Anti-rubella, Mumps and Measles IgG Antibodies in Medical Students of Tehran University.
Keshavarz M; Nicknam MH; Tebyanian M; Shahkarami MK; Izad M
Iran J Allergy Asthma Immunol; 2016 Jun; 15(3):244-50. PubMed ID: 27424140
[TBL] [Abstract][Full Text] [Related]
57. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
58. Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia.
Almuneef MA; Memish ZA; Balkhy HH; Otaibi B; Helmi M
Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1178-83. PubMed ID: 17080374
[TBL] [Abstract][Full Text] [Related]
59. Lack of serologic immunity against vaccine-preventable diseases in children after thoracic transplantation.
Urschel S; Cremer S; Birnbaum J; Dallapozza R; Fuchs A; Jäger G; Schmitz C; Belohradsky BH; Netz H
Transpl Int; 2010 Jun; 23(6):619-27. PubMed ID: 20028497
[TBL] [Abstract][Full Text] [Related]
60. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM
An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
